Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for cardiac injury in COVID-19
NCT04355143Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- May 2020
- Primary completion
- Jul 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by University of California, Los Angeles. Started May 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04355143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355143.